BANDUNG-Bio Farma Ltd. as the sole vaccine producer in Indonesia will create and develop products other than vaccine in the future. Senior researcher of Bio Farma Ltd., Erman Tritama, said that several products other than vaccine that will be produced and developed by Bio Farma are categorised as biosimilar and plasma product class.
"Now we are in the middle of processing the non-vaccine products. However, we still develop and create new vaccine products, hopefully the new kind of vaccines can be launched in 2019," he said in Media Gathering event, Sunday (19/3).
According to Erman, the non-vaccine products is biosimilar and plasma products which are approved relatively new products that will be produced by Bio Farma.
"Biosimilar is a product to accelerate the reproduction of new cell, while plasma product is the utilisation of blood plasma for the treatment and diagnosis of disease appropriately," Erman explained.
New vaccine products in addition to vaccine, which is also called life science, is expected to be produced by Bio Farma start from 2019.